Dornase alfa cleaves extracellular DNA to 5´-phosphodinucleotide and Deoxyribonuclease (human clone protein moiety); Dornasa alfa. Date of last search for all years available: 20 May Using the option ‘ Advanced search’, the following search terms were entered into the following fields. El impacto de primer año de tratamiento con dornasa alfa en los parámetros clínicos de pacientes con fibrosis quística: resultado de estudio brasileño.

Author: Dajin Arami
Country: Equatorial Guinea
Language: English (Spanish)
Genre: Literature
Published (Last): 10 September 2006
Pages: 147
PDF File Size: 4.21 Mb
ePub File Size: 19.68 Mb
ISBN: 135-5-33927-311-3
Downloads: 66270
Price: Free* [*Free Regsitration Required]
Uploader: Dataur

Part of these results was previously published Dornase alfa may be considered as a therapeutic option in non-cystic fibrosis pediatric patients with pulmonary atelectasis, who require treatment intervention when conventional therapy is unsuccessful. Treatment strategies for CF are known to be demanding and have a complex scheme.

The present paper was lafa attempt to rescue the outcomes of distinct age groups.

You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. Dornase alfa does not seem to have any effect on non-purulent sputum. Ask your doctor, dornada, or respiratory therapist to demonstrate the proper technique.

Do not stop using dornase alfa without talking to your doctor.

DNase recombinant human deoxyribonuclease. Dornasw by a mutation in the cystic fibrosis transmembrane conductance regulator CFTR gene, this disease is characterized by progressive lung destruction, with accumulation of viscous secretions and impairment of mucociliary clearance in airways 34 Chronic pulmonary infection and increased inflammatory response are hallmarks of CF lung disease, with a major impact on patients’ morbidity and the mortality 4 – 6.

It usually is taken one or two times a day. Table 2 Outpatient clinic doornasa emergency room visits, hospitalizations and pulmonary function parameters in the last 6 months prior to study entry, at 6 and 12 months after dornase alfa initiation in patients aged years. Health-related quality of life HRQoL has gained importance lately as an endpoint for clinical trials, so we have conducted a multicenter prospective study to investigate the impact of dornase alfa introduction on patients’ QoL.


Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Persistent airway colonization has a devastating impact on patient’s life spam and contributes to local inflammatory response and to progressive deterioration of lung function with age 2 P.

Dornase alfa

Overall and per age group descriptive analysis of gender, age, age at diagnosis, and clinical manifestations were previously described However, you should not flush this medication down the toilet.

At each visit, physical examination, laboratory measures, and a spirometry were performed. Patients were analyzed according to the age-groups 14 Further multicenter research will be welcomed to clarify many sornasa aspects and outcomes of CF patients without the limitations imposed by this study. The role of dornase alfa in the treatment of cystic fibrosis.

Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.

Gastrointestinal and reproductive systems are also affected with pancreatic insufficiency with maldigestion and malabsorption of nutrients, distal intestinal obstruction, and hepatic disease. We evaluated 8 clinical trials and 12 case reports involving this pediatric population with varying primary diagnoses. Pulmonary tests, airway microbiology, emergency room visits, hospitalizations, emergency and routine treatments were evaluated. This page was last edited on 17 Februaryat Sputum cultures were collected routinely and considered positive when the following microorganisms were presented in at least one sample: No positive effect of rhdnase on the pulmonary colonization in children with cystic fibrosis.


Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients dornsaa cystic fibrosis: What special precautions should I follow?

To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location — one that is up and away and out of their sight and reach.

Dornase Alfa for Non-Cystic Fibrosis Pediatric Pulmonary Atelectasis.

Articles needing additional references from December All articles needing additional references Template: Journal List Rev Paul Pediatr v. While no conclusive studies have yet been published, dornase alfa is expected to be metabolized by proteases in biofluids. Of the initial patients, four were excluded for not meeting the inclusion criteria.

During the study, patients in this group required hospitalizations; most cases lasted from 11 to 20 days and were predominantly due to pulmonary infections. Practice using the nebulizer while in his or her presence. It is important for you to keep a written list of all of the prescription and nonprescription over-the-counter medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements.

After one year of intervention, there was a significant reduction in the number of emergency room visits in the six to 11 years group. Introduction Cystic fibrosis CF is the most common life-threatening autosomal recessive disorder among Caucasians 12. Only use a nebulizer that is recommended by your doctor. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Back to top